Latest News

Yamada Holdings Co., Ltd. ( TSE:9831 ) has announced that it will be increasing its dividend from last year's...

NS Tool (TSE:6157) has reported Q3 2026 revenue of ¥2,364 million and basic EPS of ¥15.40. Trailing twelve month EPS stands at ¥51.03 and net income of ¥1,270 million provides a broader view of recent profitability. Over recent quarters, the company has seen revenue move from ¥2,389 million in Q4 2025 to ¥2,324.87 million in Q2 2026 and ¥2,364 million in Q3 2026. Quarterly EPS shifted from ¥13.89 in Q4 2025 to ¥11.25 in Q2 2026 and ¥15.40 in Q3 2026, giving investors a clear line of sight on...

AS ONE (TSE:7476) has released its Q3 2026 scorecard with revenue of ¥27,792 million and basic EPS of ¥33.42, giving investors a fresh read on how the business is tracking through the year. The company reported revenue of ¥26,744 million and EPS of ¥30.01 in Q3 2025, compared with ¥27,792 million and EPS of ¥33.42 in Q3 2026, while trailing twelve month EPS was ¥125.28 on revenue of about ¥107.6 billion. With earnings growth forecasts outpacing expected revenue growth and margins already...

If you are wondering whether Air Products and Chemicals is genuinely attractive at its current price, you are not alone. Many investors are asking if the stock still offers value after recent moves. The share price closed at US$272.50, with returns of 4.3% over the last week, 10.3% over the last month, 8.8% year to date, a 16.6% decline over the past year, 3.3% gains over three years and 21.8% gains over five years. Recent coverage around Air Products and Chemicals has focused on its...

Abhotel (TSE:6565) has reported another solid set of numbers for Q3 2026, with revenue at ¥3.5 billion and basic EPS of ¥71.11, anchored by net income of ¥1.0 billion. The company’s revenue has increased from ¥3.0 billion and basic EPS of ¥57.70 in Q3 2025 to ¥3.5 billion and ¥71.11 in Q3 2026, giving investors a clear sense of momentum in both the top and bottom line. With trailing net profit margins holding in the mid 20s, this latest print presents Abhotel as a business that is currently...

Heiwa Real Estate (TSE:8803) has released its Q3 2026 results, reporting revenue of ¥10.95b and basic EPS of ¥27.32. Trailing twelve month revenue stands at ¥47.90b and EPS at ¥161.71, supported by net income excluding extra items of ¥1.82b for the quarter. Over the past few quarters, the company’s revenue has increased from ¥8.19b in Q3 2025 to ¥10.95b in Q3 2026, with quarterly basic EPS moving from ¥22.58 to ¥27.32. The trailing twelve month net profit margin is 22.5% compared with 16.2% a...

Max (TSE:6454) has released its Q3 2026 scorecard with revenue of ¥25.6 billion, basic EPS of ¥80.26 and net income of ¥3,614 million, setting the tone for how investors assess the latest leg of its earnings story. The company reported revenue of ¥22.8 billion in Q4 2025, ¥24.4 billion in Q2 2026 and now ¥25.6 billion in Q3 2026, while basic EPS has ranged between ¥45.87 and ¥81.08 over the same period, giving a clearer view of how sales and per share profits have been pacing into this...

Kandenko Co.,Ltd. ( TSE:1942 ) has announced that it will be increasing its dividend from last year's comparable...

Charles Schwab (NYSE:SCHW) announced major executive leadership changes, including retirements and new appointments in senior roles. The company is creating a Technology, Operations, and Data organization to oversee key enterprise functions. Wealth advisory and banking operations are being consolidated under a single executive to streamline oversight. Transitions include succession for the CEO of Charles Schwab Bank and the General Auditor role. For you as an investor looking at NYSE:SCHW,...

Nisshin Seifun Group (TSE:2002) has put up a mixed Q3 2026 scorecard, with revenue of ¥222.6b and basic EPS of ¥43.73, while trailing 12 month EPS sits at ¥93.52 on revenue of about ¥858.0b. Over recent quarters, revenue has ranged from ¥204.0b in Q4 2025 to ¥222.6b in Q3 2026, with basic EPS moving between a loss of ¥4.47 in Q2 2026 and a high of ¥43.73 in the latest quarter. This is setting the stage for investors to focus closely on how margins are holding up. See our full analysis for...

Hokkaido Electric Power Company (TSE:9509) has released its Q3 2026 scorecard, reporting revenue of ¥205.8 billion and basic EPS of ¥22.87, alongside net income of ¥4.7 billion. The company’s revenue moved from ¥229.7 billion in Q3 2025 to ¥205.8 billion in Q3 2026, while EPS was broadly similar over that period at around ¥22.83 in Q3 2025 and ¥22.87 in Q3 2026. This sets up a quarter where the key question for investors is how efficiently that top line is translating into profit. See our...

Scroll (TSE:8005) has posted its Q3 2026 numbers with revenue of ¥23,351 million and basic EPS of ¥17.87, against a backdrop of trailing 12 month EPS of ¥73.52 and net income of ¥2,533 million on revenue of ¥87,108 million. The company has seen quarterly revenue move from ¥19,880 million in Q2 2025 to ¥21,188 million in Q4 2025 and then to ¥23,351 million in Q3 2026. Over the same periods, quarterly EPS has ranged from ¥34.77 in Q2 2025 to ¥11.10 in Q4 2025 and ¥17.87 in the latest quarter,...

The board of Gecoss Corporation ( TSE:9991 ) has announced that it will be increasing its dividend by 18% on the 22nd...

Tokuyama (TSE:4043) has posted Q3 2026 results with revenue of ¥87,768 million and basic EPS of ¥93.47, giving investors a fresh look at how the business is tracking into year end. The company has seen quarterly revenue move from ¥89,686 million in Q4 2025 to ¥81,828 million in Q1 2026, then to ¥81,928 million in Q2 and ¥87,768 million in Q3. Over the same stretch, basic EPS ran from ¥89.93 to ¥68.26, ¥100.55 and ¥93.47. With these figures set against trailing EPS of ¥352.21 and a net margin...

Mirum Pharmaceuticals (NasdaqGM:MIRM) has completed its acquisition of Bluejay Therapeutics, adding a late stage hepatitis delta virus treatment to its pipeline. The acquired asset carries Breakthrough Therapy and PRIME designations, highlighting regulatory focus on the underlying unmet medical need. This transaction expands Mirum's rare liver disease franchise beyond its existing portfolio into a new viral liver disease indication. For you as an investor, this deal brings Mirum further...

If you are wondering whether Ascendis Pharma's share price still makes sense after a strong run, this article will walk through what the current market price might be implying about its value. The stock last closed at US$226.10, with a 1 year return of 73.0% and a 3 year return of 94.7%, alongside a recent 7 day return showing a 3.9% decline and a 30 day and year to date return of 6.0%. Recent attention on Ascendis Pharma has been shaped by company specific developments and sector news that...

Morgan Stanley (NYSE:MS) is expanding its digital asset push with a new head of digital-asset strategy. The firm is rolling out ETFs tied to Bitcoin and Solana and is introducing the Grayscale Bitcoin Mini Trust ETF for client access. Cryptocurrency trading is being enabled on the E-Trade platform as part of a broader integration of digital assets into institutional and wealth offerings. For a global bank like Morgan Stanley, which is deeply tied into institutional and wealth management,...

Keyence Q3 2026 earnings: steady top line and firm margins Keyence (TSE:6861) has posted Q3 2026 results with revenue of ¥289,305 million and basic EPS of ¥458.54, setting the tone for another data heavy update for investors tracking its earnings momentum. The company reported revenue of ¥259,640 million in Q3 2025 and ¥289,305 million in Q3 2026, while basic EPS over the same quarters shifted from ¥420.76 to ¥458.54, with trailing 12 month EPS at ¥1,723.77. With a trailing net profit margin...

KSKLtd (TSE:9687) has put out its Q3 2026 scorecard, with revenue at about ¥6.5 billion and basic EPS of ¥52.45, alongside trailing twelve month revenue of roughly ¥25.4 billion and EPS of ¥386.57 that sits on top of 36.5% earnings growth over the past year. Over recent quarters, the company has seen revenue move from ¥5.9 billion in Q2 2025 to ¥6.5 billion in Q3 2026, while quarterly basic EPS has ranged from ¥79.96 in Q2 2025 to ¥124.24 in Q2 2026 before landing at ¥52.45 this quarter. With...

RBC and REALTOR.ca recently announced a long-term partnership to integrate mortgage education and financial advice directly into Canada's leading home search platform, creating a more seamless path from property discovery to purchase. By combining RBC's plans for AI-enabled guidance with REALTOR.ca's extensive listings, the collaboration aims to reshape how Canadians learn about and plan for homeownership within a single digital experience. Next, we will examine how this integration of...

Shareholders might have noticed that Oriental Land Co., Ltd. ( TSE:4661 ) filed its third-quarter result this time last...

Workiva Inc. recently announced changes to its board of directors, adding independent directors Scott Herren, former CFO of Cisco and Autodesk, and Mark Peek, a former senior executive at Workday, VMware, and Amazon, while Lead Independent Director David Mulcahy resigned and Suku Radia was appointed as his successor. The addition of two veteran finance and operations leaders with deep experience in large enterprise software and technology companies could influence how Workiva shapes...

Why JD.com (NasdaqGS:JD) is back on investors’ radar JD.com (NasdaqGS:JD) has drawn fresh attention after recent share price weakness, including a negative move over the past year and past 3 months, prompting investors to recheck how its fundamentals stack up. See our latest analysis for JD.com. At a share price of US$28.48, JD.com’s recent 1 day and 7 day share price declines, together with a 1 year total shareholder return of 28.04% in the red, point to fading momentum as investors reassess...

Valley National Bancorp (NasdaqGS:VLY) has appointed veteran banking executive Carlos Vazquez as an independent director. Vazquez brings decades of C suite and board experience at major financial institutions to Valley's board. He will serve on key committees focused on financial oversight, audit, and human capital governance. For you as an investor, this move sits squarely in the context of a regional bank sector that is under close scrutiny on risk management, funding stability, and board...